Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2022 Jun 19:ciac488. doi: 10.1093/cid/ciac488

Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers – Mexico, March–December 2021

Vesta L Richardson 1,, Martín Alejandro Camacho Franco 2, Aurora Bautista Márquez 3, Libny Martínez Valdez 4, Luis Enrique Castro Ceronio 5, Vicente Cruz Cruz 6, Radhika Gharpure 7,, Kathryn E Lafond 8, Tat S Yau 9, Eduardo Azziz-Baumgartner 10, Mauricio Hernández Ávila 11
PMCID: PMC9214173  PMID: 35717650

Abstract

Background

Beginning in March 2021, Mexico vaccinated childcare workers with a single-dose CanSino Biologics (Adv5-nCoV) COVID-19 vaccine. Although CanSino is currently approved for use in 10 Latin American, Asian, and European countries, little information is available about its vaccine effectiveness (VE).

Methods

We evaluated CanSino VE within a childcare worker cohort that included 1,408 childcare facilities. Participants were followed during March–December 2021 and tested through SARS-CoV-2 RT-PCR or rapid antigen test if they developed any symptom compatible with COVID-19. Vaccination status was obtained through worker registries. VE was calculated as 100% × (1−hazard ratio for SARS-CoV-2 infection in fully vaccinated vs. unvaccinated participants), using an Andersen-Gill model adjusted for age, sex, state, and local viral circulation.

Results

The cohort included 43,925 persons who were mostly (96%) female with a median age of 32 years; 37,646 (86%) were vaccinated with CanSino. During March–December 2021, 2,250 (5%) participants had laboratory-confirmed COVID-19, of whom 25 were hospitalized and 6 died. Adjusted VE was 20% (95% CI = 10–29%) against illness, 76% (42–90%) against hospitalization, and 94% (66–99%) against death. VE against illness declined from 48% (95% CI = 33–61) after 14–60 days following full vaccination to 20% (95% CI = 9–31) after 61–120 days.

Conclusions

CanSino vaccine was effective at preventing COVID-19 illness and highly effective at preventing hospitalization and death. It will be useful to further evaluate duration of protection and assess the value of booster doses to prevent COVID-19 and severe outcomes.

Keywords: Vaccine effectiveness, Ad5-nCoV, CanSino, Mexico, childcare, COVID-19

Contributor Information

Vesta L Richardson, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Martín Alejandro Camacho Franco, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Aurora Bautista Márquez, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Libny Martínez Valdez, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Luis Enrique Castro Ceronio, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Vicente Cruz Cruz, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Radhika Gharpure, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Kathryn E Lafond, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Tat S Yau, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Eduardo Azziz-Baumgartner, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Mauricio Hernández Ávila, Dirección de Prestaciones Económicas y Sociales del Instituto Mexicano del Seguro Social, Mexico City, Mexico.

Supplementary Material

ciac488_Supplementary_Data

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ciac488_Supplementary_Data

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES